About Face

Researchers show that genetic enhancer elements likely contribute to face shape in mice.

Written byAbby Olena, PhD
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

EUREKALERT, BERKELEY LABNo one person—or animal—has the exact same face shape as another. Now scientists have a better idea of how these differences, even small ones, might arise. Researchers led by Axel Visel of the Lawrence Berkeley National Laboratory in California have shown that mouse genetic enhancer sequences—DNA that does not code for proteins, but can instead modify the expression of other genes—can affect face shape. The work was published today (October 25) in Science.

“Enhancers are part of the 98 percent of the human genome that is non-coding DNA—long thought of as ‘junk DNA,’” Visel told New Scientist. “It’s increasingly clear that important functions are embedded in this ‘junk.’”

The researchers began by collecting cranio-facial tissue from embryonic mice for chromatin immunoprecipitation using p300, a protein associated with genetic enhancers, followed by sequencing. They identified 4,399 enhancer candidates throughout the genome, many of which were conserved in humans. They then generated transgenic mice with LacZ genes under the control of each of 205 of the predicted enhancers and found that 121 of the tested sequences drove some craniofacial expression. Expression varied widely between enhancers. The researchers also generated three transgenic mouse lines with deletions in three enhancers, analyzed their ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies